Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells

Cancer Research

Volumn 56, Issue 18, 1996, Pages 4255-4263

  Tallett, April ^a   Chilvers, Edwin R ^a   Hannah, Sharon ^a   Dransfield, Ian ^a   Lawson, Mark F ^a   Haslett, Christopher ^a   Sethi, Tariq ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOMBESIN; GENISTEIN; NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; PROTEIN BCL 2; PROTEIN TYROSINE KINASE; SUBSTANCE P DERIVATIVE; TYROSINE; TYRPHOSTIN;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INACTIVATION; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION;

APOPTOSIS; BOMBESIN; CARCINOMA, SMALL CELL; CELL ADHESION MOLECULES; CELL CYCLE; CELL DIVISION; ENZYME ACTIVATION; ENZYME INHIBITORS; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENISTEIN; HUMANS; ISOFLAVONES; KINETICS; LUNG NEOPLASMS; NECROSIS; NEUROPEPTIDES; NITRILES; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN-TYROSINE KINASES; RECEPTORS, NEUROPEPTIDE; SUBSTANCE P; TIME FACTORS; TUMOR CELLS, CULTURED; TYRPHOSTINS;

EID: 0029789038     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Smyth, J F , Fowlie, S. M , Gregor, A., Crompton, G. K., Busutill, A., Leonard, R C. F., and Grant, I W. B The impact of chemotherapy on small cell carcinoma of the bronchus. Quart. J. Med , 61 969-976, 1986
2. Gazdar, A. F , Helman, L. J , Israel, M A., Russell, E. K , Linnoila, R. I , Mulshine, J. L., Schuller, H M , and Park, J. G Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin a, and dense core granules in human tumors of endocrine and nonendocrine origin. Cancer Res , 48: 4078-4082, 1988.
3. Moody, T. W., Pert, C B , Gazdar, A. F , Carney, D. N , and Minna, J. D. High levels of intracellular bombesin characterize human small-cell lung carcinoma. Science (Washington DC), 214 1246-1248, 1981.
4. Heimbrook, D. C , Boyer, M. E , Garsky, V M , Balishin, N. L., Kiefer, D. M., Oliff, A., and Riemen, M. W. Minimal ligand analysis of gastrin releasing peptide, receptor binding and mitogenesis J Biol. Chem., 263, 7016-7019, 1988
5. Sausville, E. A., Lebacq-Verheyden, A. M., Spindel, E. R , Cuttitta, F., Gazdar, A. F., and Battey, J F. Expression of the gastrin-releasing peptide gene in human small cell lung cancer Evidence for alternative processing resulting in three distinct mRNAs. J. Biol. Chem., 261: 2451-2457, 1986.
6. Cuttitta, F , Fedorko, J., Gu, J A., Lebacq, V. A , Linnoila, R. I., and Battey, J. F. Gastrin-releasing peptide gene-associated peptides are expressed in normal human fetal lung and small cell lung cancer. a novel peptide family found in man. J. Clin. Endocrinol. Metab. 67: 576-583, 1988
7. Sunday, M. E., Choi, N., Spindel, E. R., Chin, W. W., and Mark, E. J. Gastrin-releasing peptide gene expression in small cell and large cell undifferentiated lung carcinomas. Hum. Pathol , 22: 1030-1039, 1991.
8. Moody, T. W., Carney, D. N., Cuttitta, F., Quattrocchi, K., and Minna, J. D. High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer. Life Sci., 37 105-113, 1985.
9. Cuttitta, F., Carney, D. N., Mulshine, J., Moody, T. W., Fedorko, J., Fischler, A., and Minna, J. D. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer Nature (Lond.), 316: 823-826, 1985.
10. 14] bombesin analogues inhibit growth of small cell lung cancer in vitro and in vivo. Cancer Res., 51: 1798-802, 1991.
11. Sethi, T., and Rozengurt, E Multiple neuropeptides stimulate clonal growth of small cell lung cancer: effects of bradykinin, vasopressin, cholecystokinin, galanin, and neurotensin. Cancer Res , 51: 3621-3623, 1991.
12. Sethi, T., Langdon, S., Smyth, J., and Rozengurt, E. Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo. Cancer Res., 52: 2737s-2742s, 1992.
13. Langdon, S , Sethi, T., Ritchie, A., Muir, M., Smyth, J. and Rozengurt, E. Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo. Cancer Res , 52: 4554-4557, 1992.
14. Trepel, J. B., Moyer, J. D., Heikkila, R , and Sausville, E. A. Modulation of bombesin-induced phosphatidylinositol hydrolysis in a small-cell lung-cancer cell line. Biochem. J , 255, 403-410, 1992.
15. Heikkila, R., Trepel, J. B , Cuttitta, F., Neckers, L. M., and Sausville, E. A. Bombesin-related peptides induce calcium mobilization in a subset of human small cell lung cancer cell lines. J. Biol Chem , 202: 16456-16460, 1987.
16. Sharoni, Y , Viallet, J., Trepel, J B , and Sausville, E. A. Effect of guanine and adenine nucleotides on bombesin-stimulated phospholipase C activity in membranes from Swiss 3T3 and small cell lung carcinoma cells. Cancer Res., 50: 5257-5262, 1990.
17. Battey, J. F., Way, J. M , Corjay, M H , Shapira, H., Kusano, K., Harkins, R., Wu, J. M., Slattery, T., Mann, E , and Feldman, R. I. Molecular cloning of the bombesin/ gastrin-releasing peptide receptor from Swiss 3T3 cells Proc. Natl. Acad. Sci. USA, 88: 395-399, 1991.
18. Kyprianou, N , English, H. F., Davidson, N E , and Isaacs, J T. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res , 51: 162-166, 1992
19. Kyprianou, N., English, H. F., and Isaacs, J. T. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation Cancer Res , 50: 3748-3753, 1990.
20. Kerr, J. F. K., Wyllie, A. H., and Currie, A. H Apoptosis, a basic biological phenomenon with wider implications in tissue kinetics. Br. J. Cancer, 26: 239-245, 1972
21. Szende, B , Zalatnai, A , and Schally, A. V. Programmed cell death (apoptosis) m pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin Proc. Natl. Acad. Sci. USA, 86: 1643-1647, 1989
22. Williams, G. T , Smith, C A , Spooner, E , Dexter, T. M., and Taylor, D. R. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis Nature (Lond), 343: 76-78, 1990
23. 11]Substance P induces apoptosis in lung cancer cell lines in vitro Biochem. Biophys. Res. Commun , 199: 1313-1319, 1994.
24. Bergamaschi, G., Rosti, V., Danova, M , Ponchio, L , Lucotti, C , and Cazzola, M. Inhibitors of tyrosine phosphorylation induce apoptosis in human leukemic cell lines. Leukemia (Baltimore), 7: 2012-2018, 1993
25. Uckun, F. M., Schieven, G. L , Tuel-Ahlgren, L M , Dibirdik, I., Myers, D. E., Ledbetter, J A , and Song, C. W Tyrosine phosphorylation is a mandatory proximal step in radiation-induced activation of the protein kinase C signaling pathway in human B-lymphocyte precursors Proc. Natl Acad Sci USA, 90: 252-256, 1993.
26. Eischen, C. M , Dick, C. J., and Leibson, P. J Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J. Immunol , 153: 1947-1954, 1994.
27. Manabe, A , Yi, T , Kumagai, M., and Campana, D. Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. I. Cytotoxicity of interferon α in acute lymphoblastic leukemia. Leukemia (Baltimore), 7: 1990-1995, 1993
28. Yao, X. R., and Scott, D W. Antisense oligodeoxynucleotides to the blk tyrosine kinase prevent anti-mu-chain-mediated growth inhibition and apoptosis in a B-cell lymphoma. Proc. Natl. Acad. Sci. USA, 90: 7946-7950, 1993.
29. Ikegaki, N., Katsumata, M., Minna, J., and Tsujimoto, Y Expression of bcl-2 in small cell lung carcinoma cells. Cancer Res., 54: 6-8, 1994.
30. Hockenbery, D., Nunez, G , Milliman, C., Schreiber, R. D., and Korsmeyer, S. J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.), 348: 334-336, 1990.
31. Otani, H., Erdos, M , and Leonard, W. J. Tyrosine kinase(s) regulate apoptosis and bcl-2 expression in a growth factor-dependent cell line J Biol. Chem., 268: 22733-22736, 1993.
32. Miyashita, T., Krajewski, S., Krajewska, M., Wang, H. G., Lin, H. K , Liebermann, D. A., Hoffman, B., and Reed, J. C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9: 1799-1805, 1995.
33. Haldar, S., Negrini, M., Monne, M., Sabbioni, S., and Croce, C. M. Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res., 54: 2095-2097, 1994.
34. Kastan, M. B., Onyekwere, O , Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6301-6311, 1991.
35. Milne, D. M., Campbell, D. G., Caudwell, F B., and Meek, D. W. Phosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases. J. Biol. Chem., 269: 9253-9260, 1994.
36. Duke, R. C., and Cohen, J. J Morphological and biochemical assays of apoptosis. In: J E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober (eds.), Current Protocols in Immunology, pp. 3.17.1-3 17.16 New York: John Wiley & Sons, 1992
37. Howard, T. H , and Meyer, W. H Chemotactic peptide modulation of actin assembly and locomotion in neutrophils J. Cell Biol , 98: 1265-1271, 1984.
38. 14]Bombesin is a specific bombesin receptor antagonist in Swiss 3T3 cells. Biochem Biophys. Res. Commun., 155: 359-365, 1988
39. Woll, P J., and Rozengurt, E. A neuropeptide antagonist that inhibits the growth of small cell lung cancer in vitro Cancer Res , 50: 3968-3973, 1990
40. Seckl, M., and Rozengurt, E. Tyrphostin inhibits bombesin stimulation of tyrosine phosphorylation, c-fos expression and DNA synthesis in Swiss 3T3 cells. J Biol Chem., 268: 9548-9554, 1993.
41. Carney, D. N , Gazdar, A. F , and Minna, J. D. Positive correlation between histological tumor involvement and generation of tumor cell colonies in agarose in specimens taken directly from patients with small cell carcinoma of the lung Cancer Res., 40 1820-1823, 1980.
42. Takahashi, T., Takahashi, T., Suzuki, H , Hida, T , Sekido, Y., Ariyoshi, Y., and Ueda, R. The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. Oncogene, 6: 1775-1778, 1991.
43. FAK): a point of convergence in the action of neuropeptides, integrins and oncogenes Cell, 71: 891-894, 1992.
44. Akiyama, T., Ishida, J., Nakagawara, S., Ogawara, S , Itoh, N., Shibuya, M., and Fukami, Y. Genistein, a specific inhibitor of tyrosine specific protein kinase. J. Biol. Chem , 262: 5592-5595, 1987
45. Gazit, A., Yaish, P , Gilon, C., and Levitzki, A. Tyrphostins I. Synthesis and biological activity of protein tyrosine kinase inhibitors. J. Med. Chem., 32: 2344-2352, 1989.
46. Lyall, R. M , Zilberstein, A., Gazit, A., Gilon, C., Levitzki, A , and Schlessinger, J. Tyrphostins inhibit epidermal growth factor (EGF)-receptor tyrosine kinase activity in living cells and EGF-stimulated cell proliferation. J. Biol Chem , 264: 14503-14509, 1989.
47. Bilder, G. E., Krawiec, J. A., McVety, K , Gazit, A., Gilon, C., Lyall, R., Zilberstein, A., Levitzki, A , Perrone, M H., and Schreiber, A. B. Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells Am J Physiol., 260: c721-c730, 1991.
48. Anafi, M , Gazit, A., Gilon, C., Ben-Neriah, Y., and Levitzki, A. Selective interactions of transforming and normal abl proteins with ATP, tyrosine-copolymer substrates, and tyrphostins. J. Biol Chem., 267: 4518-4523, 1992.
49. O'Dell, T J., Kandell, E R , and Grant, S. G. N. Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors. Nature (Lond.). 353: 558-560, 1991.
50. Ohmori, T., Podack, E R., Nishio, K., Takahashi, M , Miyahara, Y , Takeda, Y., Kubota, N., Funayama, Y., Ogasawara, H , Ohira, T., Ohta, S., and Saijo, N. Apoptosis of lung cancer cells caused by some anti cancer agents (MMC.CPT-11, ADM) is inhibited by bcl-2. Biochem. Biophys. Res. Commun., 192: 30-36, 1993.